Drug Recall

 

HPS Pharmacies wish to advise that Sandoz Pty Ltd, in consultation with the Therapeutic Goods Administration (TGA), has given notice of a drug recall of:

Fludarabine Ebewe® Vials
Fludarabine 50mg/2ml
ARTG 135540

 The only affected batch is EM8109 with an expiry of March 2017.

This recall has been initiated after yellow-brownish particles were identified in the above batch. No clinically relevant risk has been identified with the presence of these particles.

Please inspect your stocks and quarantine all products from the batch stated above for return to your supplier for a refund.

If HPS Pharmacies provide imprest management services to your facility, an HPS representative will inspect your stock and quarantine all products from the batch stated above for return to the supplier for a refund. Your HPS Pharmacies Pharmacy Manager/Director of Pharmacy will contact your clinicians if there is an immediate impact to your facility.

Retain this notice in a prominent position, including in other related business units for one month. Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies or Sandoz on 1800 726 369.

Information regarding expected dates for supply may vary subject to delays which are out of our control. HPS Pharmacies does not accept responsibility for such changes but will endeavour to keep our clients updated as information is made available from drug manufacturers or wholesalers.

Subscribe Knowledge Centre Updates

Enter your details to receive Knowledge Centre updates